We have recently shown that hypoxia confers resistance towards tyrosine kinase inhibitors (TKIs) and induces the specific expression of ARG2 in CML compared to normal progenitors [15]. The gene discussed is ARG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.